<DOC>
	<DOCNO>NCT00057070</DOCNO>
	<brief_summary>The adverse impact tobacco use disease prevalence health care cost well document . Hence , find effective way reduce tobacco dependence essential component improve outcome , quality efficiency VHA care . The U.S. Public Health Service ( PHS ) Smoking Cessation Clinical Practice Guideline provide specific recommendation treat tobacco dependence . Despite strong evidence base , however , recommendation fully integrated clinical practice within VHA . Recent data suggest logistical difficulty associate identify link smoker appropriate treatment may explain PHS Smoking Cessation Guideline broadly implement .</brief_summary>
	<brief_title>Facilitating Implementation PHS Smoking Cessation Guidelines - RESET</brief_title>
	<detailed_description>Background : The adverse impact tobacco use disease prevalence health care cost well document . Hence , find effective way reduce tobacco dependence essential component improve outcome , quality efficiency VHA care . The U.S. Public Health Service ( PHS ) Smoking Cessation Clinical Practice Guideline provide specific recommendation treat tobacco dependence . Despite strong evidence base , however , recommendation fully integrated clinical practice within VHA . Recent data suggest logistical difficulty associate identify link smoker appropriate treatment may explain PHS Smoking Cessation Guideline broadly implement . Objectives : The primary objective study ass effectiveness intervention increase rate tobacco dependence treatment population smoker identify VA Pharmacy Benefits Management database . Secondary objective study include ( 1 ) assess effect intervention smoking cessation rate , ( 2 ) develop option overcome potential barrier broad implementation strategy . Methods : The effectiveness intervention evaluate use multi-center , randomize , control trial . Veterans receive prescription transdermal nicotine , nicotine gum , bupropion smoking cessation past year one participating VHA facility ( determine Pharmacy Benefits Management record ) eligible study . A total 1,900 eligible veteran select five test site randomly assign one two group : ( 1 ) patient phone call tailor , computerized prompt provider ( intervention ) , ( 2 ) usual care ( control ) . The primary outcome proportion patient receive pharmacological smoking cessation treatment six month follow-up period , assess VA pharmacy outpatient data file . All patient recruit brief phone interview six month post-intervention gather secondary outcome measure data relate smoking status , quit history , use smoking cessation assistance . Status : Data preparation analysis .</detailed_description>
	<criteria>Subjects must receive prescription smoke cessation medication 2002 .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>